GastroIntestinal / Gastroentor List
Non-Steroidal Anti-Inflammatory Drug Applied to Skin Lessens Muscle Soreness Aft
Diet may play role in IBS and dyspepsia
Study findings question COX-2 drug cost effectiveness
Beware of alternative treatments for autism
Does giving good bacteria reduce infections?
Gastric bypass surgery riskiest for those who need it most
European Regulators Reaffirm Pfizer's COX-2 Portfolio
Cannabinoids spell relief in colon inflammation
PET scans superior in revealing response to treatment for gastrointestinal strom
Data show investigational antibiotic rifaximin safe, effective in preventing tra
First Ever Trial Comparing Biologic Therapy With Conventional Therapy in Patient
Surgery safer at teaching hospitals
Elan and Biogen Idec announce results from Phase III maintenance trial of Antegr
Mechanism between areas of the brain and continence
Many people overdosing on pain killers
ESOMEPRAZOLE offers at-risk patients effective protection from nsaid associated
Digestive Disease Week Turning Science into Medicine
Infusion Of Two Peptides Acts To Accelerate Appetite Satisfaction
M2A capsule endoscopy improves clinical outcomes in IBD patients
Approval recommended for use of Zelnorm(reg) in chronic constipation by FDA Advi
Cox-2 Inhibitors Reduce Complications After Laparoscopic Surgery
Fatty Acids Effectiveness In Appetite Suppression Can Be Measured By The Length
Adolor Completes Submission of NDA for Entereg (TM) (alvimopan) in Postoperative
New surgery tools and technique no abdominal incisions or scars
Acceptance of final Visicol (REG) Phase IV constipation study results for presen
Chemotherapy and supportive care are a winning combination
Performing Large Volume Paracentesis as an Outpatient Procedure
Contents of The Lancet, Volume 264, August 21 to 27
Eosinophilic esophagitis is a rapidly rising disorder
FDA Approves Zelnorm as the First Rx Therapy For Chronic Constipation
FDA Accepts Entereg (TM) (alvimopan) New Drug Application (NDA)
Inkine Initiates Phase III Study of Advanced Generation Purgative Product, INKP-
Esomeprazole Offers at Risk Patients Effective Protection from NSAID Associated
Glivec (REG) significantly improves progression-free survival for patients with
Pfizer Affirms Celebrex Safety in response to withdrawal of Merck's Vioxx
FOSRENOL(R) maintains bone health status of end-stage renal disease patients
Zelnorm (REG) is effective in repeated treatment of Irritable Bowel Syndrome wi
Help for Dialysis Patients - Fosrenol Approved by FDA
Using Hand Sanitizer Stops Germs from Spreading
Endoscopy is Highly Safe Procedure Due to Training and Equipment Cleaning Guidel
New Data Show Bonviva Effective as a Once-Monthly Oral Formulation for Osteoporo
Generic anti-inflammatory causes significantly fewer GI complications than brand
ESMO & Imedex announce partnership for the World Congress on Gastrointestinal Ca
What Should Celebrex & Bextra Users Do?
Evidence Challenges Widespread Current Beliefs on the Treatment of Constipation
Novartis temporarily withdraws EU application for Prexige (REG)
FDA Grants REMICADE(reg) (Infliximab) Fast Track Designation for Active Ulcerati
Low-dose aspirin & stomach ulcer medications better for heart patients with GI c
